ISSN No. : 2584-2757

Volume

: 04

Issue

: 01

Abstract

Background:

Vātarakta

is

a

complex,

progressive

clinico-pathological

entity

in

Ayurveda

characterized

by

the

simultaneous aggravation and profound interaction of

Vāta Doṣa

and

Rakta Dhatu

. While contemporary biomedical science

often correlates it broadly with gout and inflammatory arthropathies, the classical

Ayurvedic

treatises (

Bṛhat

-

trayī

) elucidate

a highly specific pathogenesis rooted in

Mārga Avarodha

(channel obstruction) and s

equential Doṣa

-

Dūṣya Saṃmūrchana.

Despite

extensive

descriptions

in

classical

texts,

a

critical,

comparative

synthesis

prioritizing

Charaka

Saṃhitā’s

foundational pathophysiological architecture remains inadequately explored in modern literature

.

Objective:

To

critically

analyse

and

conceptually

synthesize

the

Nidāna

(etiology),

Samprāpti

(pathogenesis),

Bheda

(classification),

and

Chikitsā

(management)

of

Vātarakta

as

described

in

the

Bṛhat

-

trayī

,

with

a

special

emphasis

on

Charaka Saṃhitā

, and to evaluate its contemporary relevance to inflammatory arthropathies.

Materials and Methods:

A qualitative textual analysis and comparative conceptual synthesis were conducted. Primary

data

were

extracted

from

the

Charaka

Saṃhitā,

Suśruta

Saṃhitā

,

and

Aṣṭāṅga

Hṛdaya

alongside

their

authoritative

commentaries.

Secondary

data

included

Scopus

and

PubMed-indexed

peer-reviewed

publications.

The

evidence

was

hierarchically categorized to strictly delineate classical textual statements from modern pathophysiological interpretations.

Results:

Charaka

Saṃhitā

establishes

a

unique paradigm

wherein

Vātarakta

is

neither

exclusively

a

Vāta

disorder

nor

solely

a

Rakta

disorder,

but

a

discrete

entity

arising

from

bidirectional

pathological

obstruction

(

Avarodha

).

The

comparative analysis reveals that while

Charaka

emphasizes the systemic metabolic and circulatory interaction (

Vāta

-Rakta

Saṃmūrchana

),

Suśruta

elaborates on structural and surgical dimensions (

Raktamokṣaṇa

), and

Vāgbhaṭa

provides a highly

structured clinico-therapeutic synthesis. A reconstructed

Samprāpti

model links dietary indiscretions directly to

Srotoduṣṭi

and

Sthāna Saṃśraya

in the distal joints.

Conclusion:

Vātarakta

represents

an

autonomous,

multidimensional

disease

model.

Charaka’s

conceptualization

emphasizes

the

restoration

of

Vāta

gati

(movement)

and

Rakta

prasādana

(blood

purification)

through

stage-specific

Śodhana

and

Śamana

.

While

presenting

overlapping

phenotypes

with

modern

gout

(hyperuricemia),

Vātarakta

encapsulates a broader spectrum of neuro-vascular and inflammatory pathologies.

Keywords:

Vātarakta, Charaka Saṃhitā, Bṛhat

-

trayī

, Pathogenesis (

Samprāpti

), Gout, Inflammatory Arthropathy,

Mārga

Avarodha

.

Introduction :

• 1.
  To
  identify
  the
  primary
  etiological
  factors
  (Nidāna)
  and
  classify
  them
  systematically
  based on the Bṛhat
  -
  trayī.
• 2.
  To
  analyse
  the
  distinct
  pathophysiological
  progression
  (Samprāpti)
  of
  Vātarakta,
  mapping
  the
  specific
  roles
  of
  Mārga
  Avarodha and Srotoduṣṭi.
• 3.
  To
  compare
  the
  clinical
  descriptions,
  classifications
  (Bheda),
  and
  therapeutic
  principles across Charaka Saṃhitā, Suśruta
  Saṃhitā, and Aṣṭāṅga Hṛdaya.
• 4.
  To
  evaluate
  the
  linkage
  between
  the
  classical
  pathogenesis
  of
  Vātarakta
  and
  its
  targeted
  stage-specific
  management
  (Chikits
  ā).
• 5.
  To
  synthesize
  an
  integrated
  conceptual
  pathophysiological model of Vātarakta.
• 6.
  To correlate the classical entity of Vātarakta
  with
  modern
  biomedical
  equivalents
  (like
  gout)
  while
  preserving
  disease
  individuality.

• 1.
  What are the princi
  pal Nidāna of Vātarakta
  described
  in
  the
  Bṛhat
  -
  trayī,
  and
  how
  do
  they simultaneously vitiate Vāta and Rakta?
• 2.
  How
  does
  Charaka
  conceptualize
  the
  bidirectional
  interaction of Vāta and Rakta
  compared to other classical authors?

• 3.
  What
  are
  the
  core
  similarities
  and
  differences in Samprāpti and Bheda among
  the Bṛhat
  -
  trayī texts?
• 4.
  How
  do
  different
  stages
  (Uttāna
  and
  Gambhīra) manifest clinically, and how do
  these dictate therapeutic modifications?
• 5.
  How does the Chikitsā Siddhānta (treatment
  principle)
  directly
  correspond
  to
  the
  underlying Samprāpti?
• 6.
  What
  is
  distinctive
  about
  Charaka’s
  therapeutic approach to Vātarakta?
• 7.
  To
  what
  extent
  can
  Vātarakta
  be
  scientifically
  correlated
  with
  modern
  gout,
  and
  where
  do
  the
  phenomenological
  boundaries diverge?

• 
  Level I: Direct classical textual evidence.
• 
  Level
  II:
  Classical
  commentary-based
  interpretation.
• 
  Level III: Author's conceptual synthesis.
• 
  Level
  IV:
  Contemporary
  biomedical
  correlation.

Compendi um	Sthā na	Adhyā ya	Key Focus Area	Refere nce Nature
Charaka Saṃhitā	Cikit sā Sthān a	Adhyā ya 29	Comprehensi ve Nidāna, Samprāpti, Bheda, and profound Śodhana/Śa mana Chikitsā.	Level I

Compendi um	Sthā na	Adhyā ya	Key Focus Area	Refere nce Nature
Suśruta Saṃhitā	Nidā na Sthān a	Adhyā ya 1	Pathophysiol ogy, spatial progression (Pādamūla), surgical aspects.	Level I
Suśruta Saṃhitā	Cikit sā Sthān a	Adhyā ya 5	Raktamokṣaṇ a, Lepa, and structural joint management.	Level I
Aṣṭāṅga Hṛdaya	Nidā na Sthān a	Adhyā ya 16	Synthesized etiology and clinical presentation.	Level I
Aṣṭāṅga Hṛdaya	Cikit sā Sthān a	Adhyā ya 22	Highly structured therapeutic protocols integrating preceding concepts.	Level I

Categor y	Charak a Saṃhit ā	Suśruta Saṃhitā	Aṣṭāṅga Hṛdaya	Interpretat ion (Level III)
Āhāraja (Diet)	Lavana, Amla, Katu, Kṣāra, Snigdha , Uṣṇa. Virudd ha Āhāra.	Heavy diets, excessive alcohol, meat of aquatic/mar shy animals.	Mirrors Charaka, emphasiz es Vidāhī and Amla foods.	Pro - inflammator y diets high in purines, salts, and fats.
Vihāraj a (Lifestyl e)	Sedenta ry lifestyle , daytime sleep, riding animals .	Excessive riding, long- distance walking, trauma.	Day sleep, excessiv e trauma to joints, sedentar y habits.	Mechanical stress on dependent joints combined with metabolic stasis.

Categor y	Charak a Saṃhit ā	Suśruta Saṃhitā	Aṣṭāṅg a Hṛday a	Interpretation (Level III)
Constitu tion	Sukumā ra (delicat e), obese individu als.	Mentions structural vulnerabi lity.	Highlig hts Sukum āra and Sthūla.	Genetic/constit utional predisposition to metabolic overload.

Parameter	Charaka Saṃhitā	Suśruta Saṃhitā	Aṣṭāṅga Hṛdaya
Initial Stage	Doṣa - Dūṣya interaction and mutual aggravation .	Vāta aggravated by trauma/ridin g interacts with Rakta.	Synchronize d aggravation of both components.
Avarodha Mechanis m	Explicitly defines Mārga Avarodha (obstructio n of channels by Rakta).	Implies obstruction leading to stasis.	Re- emphasizes Charaka's Avarodha concept.
Direction of Spread	Akhuviṣava t (like rat poison, spreading insidiously) .	Pādamūla to upward spread.	Mat ches Suśruta (from feet/hands upwards).

• 1.
  Nidāna
  Sevana
  :
  Consumption
  of
  Vidāhī,
  Amla,
  Kṣāra
  foods
  +
  Sedentary
  lifestyle
  +
  Mechanical trauma.
• 2.
  Doṣa Prakopa & Rakta Duṣṭi
  : Simultaneous
  aggravation of Vāta (due to trauma/dryness)
  and Rakta (due to acidic/hot foods).
• 3.
  Mārga Avarodha:
  The morbid, heavy Rakta
  rapidly
  blocks
  the
  subtle
  channels
  (Srotas)
  of Vāta.
• 4.
  Vāta
  -
  Rakta
  Saṃmūrchana
  :
  The
  obstructed
  Vāta further aggravates, disrupting the flow
  of Rakta. They mutually vitiate each other.
• 5.
  Sthāna
  Saṃśraya
  :
  Due to gravity, vascular
  anatomy, and structural stress, the complex
  lodges
  in
  the
  dist
  al
  extremities
  (Pāda,
  Hasta).
• 6.
  Vyakti:
  Manifestation of severe pain (Toda,
  Bheda),
  inflammation
  (
  Śotha
  ),
  and
  discoloration (
  Vaivarṇya
  ).

Samprāpti Ghaṭaka	Classical Reference/Interpretation
Doṣa	Vāta (Vyāna) and Pitta/Kapha (as Anubandha).
Dūṣya	Rakta (primary), Mamsa, Asthi, Majjā, Sandhi (in Gambhīra).
Agni	Jaṭharāgni Māndya, Dhātvāgni Māndya (metabolic defect).
Ama	Sāma state initially; contributes to Avarodha.
Srotas	Raktavaha, Māmsavaha, Asthivaha.
Srotoduṣṭi	Saṅga (obstruction), Vimārgagamana (diversion of flow).
Udbhava Sthāna	Āmāśaya / Pakvāśaya.
Sañcāra	Tiryag Gāmi Sirā (peripheral vascular channels).
Sthāna Saṃśraya	Pādamūla, Karamūla, Sandhi (joints).
Rogamārga	Bāhya progressing to Madhyama (Marmāsthisandhi).
Sādhyāsādhyatva	Kṛcchrasādhya (difficult to cure) to Yāpya/Asādhya if chronic.

Type / Stage	Classic al Descri ption	Domina nt Patholo gy	Clinical Manifest ations	Progno stic Signific ance
Uttāna (Superf icial)	Locate d in Twak (skin) and Māmsa (muscl e).	Microva scular / Cutaneo us.	Itching (Kandu), burning, pain, skin discolorat ion, superficia l nodules.	Sādhya (Curabl e) if treated early.

Type / Stage	Classic al Descrip tion	Domina nt Patholo gy	Clinical Manifes tations	Prognos tic Signific ance
Uttāna (Super ficial)	Located in Twak (skin) and Māmsa (muscle ).	Microva scular / Cutaneo us.	Itching (Kandu), burning, pain, skin discolora tion, superfici al nodules.	Sādhya (Curable ) if treated early.
Gamb hīra (Deep)	Located in Dhātus, Asthi, Majjā, Sandhi (joints).	Synovia l / Osseous / Articula r.	Deep- seated piercing pain, gross swelling, joint deformit y, systemic fever.	Kṛcchra sādhya or Yāpya (Palliati ve).
Vāta - domin ant	Charact erized by extreme pain and neuro - vascular spasms.	Vāta Prakopa .	Tearing pain, twitchin g, dryness, stiffness, severe cold sensitivit y.	Require s profoun d Sn ehana (oleatio n).
Rakta/ Pitta- domin ant	Charact erized by intense acute inflam mation.	Pitta/Ra kta Duṣṭi.	Burning sensation , redness, severe tenderne ss, heat, suppurati on.	Require s Raktam okṣaṇa and Śīta Upacāra .
Kapha - domin ant	Charact erized by structur al edema and stasis.	Kapha Avarod ha.	Heavines s, cold swelling, numbnes s, mild pain.	Require s Rūkṣana and Uṣṇa therapie s.

Stage	Systemic / Local Manifestations	Modern Correlate (Level IV)
Pūrvārūpa (Prodrome)	Hyperhidrosis or anhidrosis, hyperesthesia, formication, joint laxity, discoloration.	Asymptomatic hyperuricemia, early vascular endothelial dysfunction.
Rūpa (Acute)	Sudden onset agonizing pain, localized erythema, burning sensation (Daha), extreme tenderness (Sparśāsahatva).	Acute gouty flare, intense synovial inflammation, podagra.
Chronic Complications	Hard subcutaneous nodules, joint contractures (Khañjatva), structural deform ity.	Tophaceous gout, chronic gouty arthropathy, joint destruction.

Pathologi cal Compone nt	Therapeu tic Target	Classical Interventi on	Rationale
Rakta Duṣṭi & Avarodha	Srotoshod hana / Rakta Prasādana	Raktamok ṣaṇa (Bloodletti ng - Jalaukā or Sirāvedha) .	Immediately relieves local vascular congestion and expels morbid Rakta [1, 2].
Vāta Prakopa & Pain	Vāta Anuloman a / Snehana	Basti (Medicate d enemas - Anuvasan a and Niruha).	Basti is the paramount therapy for Vāta. Specifically, Kṣīrabasti (milk-based) pacifies both V āta and Rakta.
Sāma / Srotoduṣṭ i	Āmapācan a / Mild Śodhana	Mṛdu Virecana (Mild purgation) using unctuous or dry drugs depending on Dosha.	Clears the gastrointestina l tract and lowers metabolic load (Pitta/Rakta relation).
Local Inflamma tion	Śothahara / Daha Śamana	Lepa (Poultice) and Pariṣeka (Pouring medicated liquids).	Topical application of cooling, anti- inflammatory herbs (e.g., Daśāṅga Lepa) rapidly reduces local signs.
Chronic Pathology	Śamana / Rejuvenati on	Internal administra tion of Gudūcī and G uggulu.	Gudūcī is the drug of choice (Agrya) for Vātarakta due to its immunomodu latory and uricosuric - like actions [6, 7].

Categ ory	Pathya (Whole some)	Classical Rational e	Apathya (Unwhol esome)	Classic al Ration ale
Āhār a (Diet)	Old wheat, barley (Yava), Sāthi rice, cow's milk, Ghṛta, meat soup of arid animals .	Non - obstructiv e (Srotosho dhaka), balances Vāta without vitiating Rakta.	Kulattha, Urad dal, alka line foods (Kṣāra), curd, alcohol, heavy meats.	Highly inflam matory, causes Vidāha, increase s Rakta toxicity.
Vihār a (Lifes tyle)	Gentle joint mobilit y, adequat e rest, moderat e climate.	Prevents Srotas stasis.	Day sleep, intense exercise, trauma, excessive heat exposure.	Induces Vāta Prakopa and Mārga Avarod ha.

Parameter	Classical Vātarakta	Contemporary Gout (Level IV)
Primary Etiology	Diet/Lifestyle → Vāta & Rakta vitiation.	Purine - rich diet/genetics → Hyperuricemia.
Pathophysi ology	Mārga Avarodha (Vascular/channe l obstruction).	Monosodium urate (MSU) crystal deposition triggering innate immune response [8].

Parameter	Classical Vātarakta	Contemporary Gout (Level IV)
Onset Site	Pādamūla (Feet) and Karamūla (Hands).	1st Metatarsophalangeal joint (Podagra).
Progression	Superficial (Uttāna) to Deep (Gambhīra).	Asymptomatic hyperuricemia → Acute flare → Intercritical gout → Chronic tophaceous gout [9].
Manageme nt Focus	Cleansing Rakta, pacifying Vāta, restoring channel patency.	Lowering serum urate, reducing inflammation (NSAIDs, Colchicine, Urate - lowering therapy) [10].

Pathologic al Stage	Direct Textual Evidence (Level I)	Conceptual Interpretati on (Level III)	Contempora ry Biomedical (Level IV)
Initiation	Vāta and Rakta become aggravate d by specific Nidānas.	Metabolic overload plus mechanical stress.	Purine dysmetabolis m leading to hyperuricemi a.

Pathologic al Stage	Direct Textual Evidence (Level I)	Conceptual Interpretatio n (Level III)	Contempora ry Biomedical (Level IV)
Interactio n	Rakta obstructs the path of Vāta (Mārga Avarodh a).	Inflammatory stasis and impaired microcirculati on.	Monosodium Urate (MSU) crystallizatio n causing endothelial distress and inflammatory cytokine release [13].
Localizati on	Settles in Pādamūl a.	Gravity and poor distal vascular return favor distal joints.	Lower temperatures in peripheral joints decrease MSU solubility, favoring precipitation [14].

• 1.
  Sharma PV, translator. Charaka Samhita of
  Agnivesha (Text with English Translation).
  Vol
  2.
  Varanasi:
  Chaukhambha
  Orientalia;
  2014. (Cikitsā Sthāna 29).

• 2.
  Shastri
  KA,
  editor.
  Sushruta
  Samhita
  of
  Maharshi
  Sushruta.
  Varanasi:
  Chaukhambha
  Sanskrit
  Sansthan;
  2014.
  (Nidāna Sthāna 1, Cikitsā Sthāna 5).

• 3.
  Murthy
  KRS,
  translator.
  Ashtanga
  Hridayam
  of
  Vagbhata.
  Vol
  2.
  Varanasi:
  Krishnadas
  Academy;
  2016.
  (Nidāna
  Sthāna 16, Cikitsā Sthāna 22).

• 4.
  Khot
  GA,
  Yadav
  SM.
  Vatarakta
  in
  Ayurveda:
  Classical
  concepts,
  contemporary
  correlation
  with
  gout
  and
  evidence-based
  management.
  World
  J
  Pharm Res. 2026;15(19):117-131.

• 5.
  Dalal
  S,
  et
  al.
  Gout.
  StatPearls
  [Internet].
  Treasure Island (FL): StatPearls Publishing;
  2026.

• 6.
  Ramachandran AP, Prasad SM, Prasad UN,
  Jonah S. A comparative study of Kaishora
  Guggulu
  and
  Amrita
  Guggulu
  in
  the
  management
  of
  Utthana
  Vatarakta.
  AYU.
  2010;31(3):410-415.

• 7.
  Sharma
  R,
  Amin
  H,
  Galib,
  Prajapati
  PK.
  Therapeutic
  attributes
  of
  Guduchi
  (Tinospora
  cordifolia).
  AYU.
  2013;34(1):16-20.

• 8.
  Ahn
  EY,
  So
  MW.
  The
  pathogenesis
  of
  gout. J Rheum Dis. 2024;32(1):8-16.
• 9.
  Qaseem A, et al. Clinical Guidelines for the
  Management
  of
  Gout.
  Ann
  Intern
  Med.
  2025;178(3):23-35.

• 10.
  Du L, Zong Y, Li H, et al. Hyperuricemia
  and
  its
  related
  diseases:
  mechanisms
  and
  advances
  in
  therapy.
  Signal
  Transduct
  Target Ther. 2024;9(1):210.

• 11.
  Kurande V. Case Report on the Ayurvedic
  Management
  of
  Vatarakta
  w.s.r
  to
  Elderly
  Onset
  Rheumatoid
  Arthritis.
  Int
  J
  Res
  Ayurveda Allied Sci. 2026.

• 12.
  Deshpande SV, Deshpande VS, Potdar SS.
  Effect
  of
  panchakarma
  and
  Ayurvedic
  treatment in postpartum rheumatoid arthritis
  (Amavata): A case study. J Ayurveda Integr
  Med. 2017;8(1):42-44.

• 13.
  Jin
  M.
  Uric
  acid,
  hyperuricemia
  and
  vascular
  diseases.
  Front
  Biosci.
  2012;17(2):656-669.

• 14.
  Choi
  HK,
  Mount
  DB,
  Reginato
  AM.
  Pathogenesis
  of
  gout.
  Ann
  Intern
  Med.
  2005;143(7):499-516.